Skip to content
AnalystLens

Fortive 8-K Report, Financial Results (Jul 30, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed July 30, 2025
Period End
July 30, 2025
Security
FTV
In the record · 2016–202610-K1010-Q328-K120

FTV filed 10 annual reports (10-K), 32 quarterly reports (10-Q) and 120 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Oct ’18Oct ’18
  2. Deal closed8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Dec ’22Dec ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed July 30, 2025. Cited figures are marked; the original filing is the authoritative source.

Fortive Corporation reported second-quarter 2025 results for the quarter ended June 27, 2025, the first quarter after completing the spin-off of Ralliant on June 28, 2025.

On a continuing operations basis, which treats Ralliant (formerly the Precision Technologies segment) as discontinued operations for the prior period, revenue was $1.02 billiona, down 0.4% year-over-year, with core revenue declining 0.7%. GAAP net income was $112 million, an 11.0% margin, and adjusted EBITDA was $288 million, a 28.4% margin. GAAP diluted EPS was $0.33 and adjusted diluted EPS was $0.58.

Management cited uncertainty around trade, healthcare and government spending policy as weighing on demand in the quarter. Cash generation was a highlight. GAAP operating cash flow was $205 millionb and free cash flow was $180 million for the quarter, with trailing twelve-month free cash flow of $939 million.

The company deployed $345 millionc toward share repurchases in the first half of 2025. On a consolidated basis including Precision Technologies, GAAP diluted EPS was $0.49 and adjusted diluted EPS was $0.90, at the high end of the guidance range. Fortive initiated full-year 2025 guidance for the new Fortive, projecting adjusted diluted net earnings per share of $2.50 to $2.60 on a continuing operations basis.

Management stated that the medium-term financial framework presented at its recent Investor Day remains intact. Beginning in the third quarter of 2025, Ralliant will be reported as a discontinued operation.

Key Highlights

  1. Completed the separation of Ralliant on June 28, 2025, distributing one Ralliant share for every three Fortive shares held on the June 16, 2025 record date.
  2. Continuing operations revenue of $1.02 billion, down 0.4% year-over-year, with core revenue decline of 0.7%.
  3. GAAP net income of $112 million (11.0% margin) and adjusted EBITDA of $288 million (28.4% margin) on a continuing operations basis.
  4. GAAP diluted EPS of $0.33 and adjusted diluted EPS of $0.58 for continuing operations; consolidated adjusted diluted EPS of $0.90, at the high end of guidance.
  5. Operating cash flow of $205 million and free cash flow of $180 million in the quarter; trailing twelve-month free cash flow of $939 million.
  6. Initiated full-year 2025 adjusted diluted EPS guidance of $2.50 to $2.60 for the new Fortive.
  7. Deployed $345 million toward share repurchases in the first half of 2025; Intelligent Operating Solutions adjusted EBITDA margin was 33.8%, and Advanced Healthcare Solutions was 26.9%.

Frequently Asked Questions

  1. What is the full-year 2025 outlook for the new Fortive?

    Fortive anticipates adjusted diluted net earnings per share of $2.50 to $2.60 for full-year 2025, on a continuing operations basis that reflects Fortive without Ralliant.

  2. How did the Ralliant spin-off affect the reported results?

    Ralliant was distributed to shareholders on June 28, 2025. Beginning in the third quarter of 2025, Ralliant will be classified as a discontinued operation. Continuing operations results for Q2 2025 and Q2 2024 were presented as if Ralliant had been discontinued in those periods. Consolidated results still include Precision Technologies for both quarters.

  3. How much revenue and growth did the continuing business deliver?

    Revenue was $1,016 million, down 0.4% year-over-year, with core revenue declining 0.7%. Intelligent Operating Solutions revenue was $697 million, up 0.1% as reported and down 0.2% on a core basis. Advanced Healthcare Solutions revenue was $320 million, down 1.3% as reported and down 1.9% on a core basis.

  4. What did management say about demand and capital returns?

    The CEO cited uncertainty related to trade, healthcare and government spending policy as affecting demand in the second quarter. The company deployed $345 million toward share repurchases in the first half of 2025, and management said its disciplined capital allocation approach is a focus of the Fortive Accelerated strategy.